Zhifei Biological Jumped to AA in MSCI ESG Rating

Recently, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "the Company", "Company", or "Zhifei Biological") received a rating of AA (on a scale of AAA-CCC) in the MSCI ESG Ratings assessment, ranking in the first tier of the Biotechnology sector in China.

MSCI, a leading investment research team, provides MSCI ESG Ratings on global public and a few private companies on a scale of AAA (leader) to CCC (laggard), according to exposure to industry-specific ESG risks and the ability to manage those risks relative to peers. ZHIFEI-BIOL is rated top among global companies on Product Safety & Quality, Access to Health Care, Human Capital Development. The result in ESG rating not only demonstrates a breakthrough improvement in ZHIFEI-BIOL's ESG performance, but also reflects the market's affirmation of ZHIFEI-BIOL's sustainable development value.

Since its establishment, ZHIFEI-BIOL has always adhered to the business philosophy of "Prioritizing social benefits over corporate profits" and actively integrating the concept of sustainable development into the Company's operations. ZHIFEI-BIOL always gives top priority to R&D innovation and remains committed to driving its development via research. The Company actively implements sustainable development practices and has organically combined corporate governance, green development protection, employee care and other areas of responsibility with business operations, working with all stakeholders to promote the sustainable development of the industry and society. Since listing, the Company has been making cash or medical donations for poverty alleviation, disaster relief, elderly and children care, rural revitalization and others. The Company has donated money and supplies of over RMB 400 million in total in recent years and has been awarded with China Top 500 Enterprises in Philanthropy for 3 consecutive years.

Looking forward to the future, ZHIFEI-BIOL will always uphold the grand vision of building a "world-class biopharmaceutical enterprise", committed to serving people's health and continuously providing better products to meet their health needs. Adhering to our original mission of "safeguarding human health, by preventing the unseen & treating the ailing", we are cultivating new quality productive forces, providing high-quality products to meet the health needs of the public, and taking practical actions to build a healthy China.